Comparative efficacy of non-ablative radiofrequency and promestriene in management of the genitourinary syndrome and sexual dysfunction in cervical cancer survivors: a pilot randomized trial
Both promestriene and (NARF) significantly improve sexual function and alleviate vaginal symptoms in women treated with radiotherapy for CC, presenting viable options for managing GUS in this patient population.
Authors
- Aline C. Tregnago (ORCID: https://orcid.org/0000-0001-7370-3370)
- Márcia Luiza Montalvão Appel Binda (ORCID: https://orcid.org/0000-0002-1961-4710)
- Janete Vettorazzi (ORCID: https://orcid.org/0000-0001-9278-6861)
- Gabriel Cardozo Müller (ORCID: https://orcid.org/0000-0001-6707-5996)
- Rodrigo Rossi Balbinotti
- Lúcia Maria Kliemann (ORCID: https://orcid.org/0000-0003-0217-586X)
- Valentino Antônio Magno (ORCID: https://orcid.org/0000-0002-0972-8175)
- Fernanda Santos Grossi (ORCID: https://orcid.org/0000-0002-1852-2048)
- Luciana Borges Chagas
Institutions
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade de Caxias do Sul (BR)
- Hospital de Clínicas de Porto Alegre (BR)
Publication Details
- Journal
- The Journal of Sexual Medicine
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1093/jsxmed/qdaf083
- Citations
- 2
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59